chr10-110133615-CTAAA-C
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6
The NM_016824.5(ADD3):c.*2_*5delTAAA variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.000251 in 1,570,816 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
 Genomes: 𝑓 0.00026   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.00025   (  0   hom.  ) 
Consequence
 ADD3
NM_016824.5 3_prime_UTR
NM_016824.5 3_prime_UTR
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  5.44  
Publications
0 publications found 
Genes affected
 ADD3  (HGNC:245):  (adducin 3) Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced adducin gamma transcripts encoding different isoforms have been described. The functions of the different isoforms are not known. [provided by RefSeq, Jul 2008] 
ADD3 Gene-Disease associations (from GenCC):
- cerebral palsy, spastic quadriplegic, 3Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - complex neurodevelopmental disorder with motor featuresInheritance: AR Classification: MODERATE Submitted by: ClinGen
 - spastic quadriplegic cerebral palsyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -1 ACMG points.
BP6
Variant 10-110133615-CTAAA-C is Benign according to our data. Variant chr10-110133615-CTAAA-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445451.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ADD3 | ENST00000356080.9  | c.*2_*5delTAAA | 3_prime_UTR_variant | Exon 15 of 15 | 1 | NM_016824.5 | ENSP00000348381.4 | |||
| ADD3 | ENST00000277900.12  | c.*2_*5delTAAA | 3_prime_UTR_variant | Exon 14 of 14 | 1 | ENSP00000277900.8 | ||||
| ADD3 | ENST00000360162.7  | c.*2_*5delTAAA | 3_prime_UTR_variant | Exon 14 of 14 | 1 | ENSP00000353286.3 | 
Frequencies
GnomAD3 genomes   AF:  0.000263  AC: 40AN: 152078Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
40
AN: 
152078
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000359  AC: 77AN: 214620 AF XY:  0.000349   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
77
AN: 
214620
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000250  AC: 354AN: 1418738Hom.:  0   AF XY:  0.000253  AC XY: 178AN XY: 703960 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
354
AN: 
1418738
Hom.: 
 AF XY: 
AC XY: 
178
AN XY: 
703960
show subpopulations 
African (AFR) 
 AF: 
AC: 
3
AN: 
31148
American (AMR) 
 AF: 
AC: 
4
AN: 
35390
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
100
AN: 
24278
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
39342
South Asian (SAS) 
 AF: 
AC: 
8
AN: 
79050
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
48772
Middle Eastern (MID) 
 AF: 
AC: 
29
AN: 
5544
European-Non Finnish (NFE) 
 AF: 
AC: 
170
AN: 
1096694
Other (OTH) 
 AF: 
AC: 
39
AN: 
58520
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.488 
Heterozygous variant carriers
 0 
 16 
 33 
 49 
 66 
 82 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.000263  AC: 40AN: 152078Hom.:  0  Cov.: 32 AF XY:  0.000175  AC XY: 13AN XY: 74288 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
40
AN: 
152078
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
13
AN XY: 
74288
show subpopulations 
African (AFR) 
 AF: 
AC: 
4
AN: 
41400
American (AMR) 
 AF: 
AC: 
3
AN: 
15258
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
12
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5192
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10598
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
19
AN: 
68022
Other (OTH) 
 AF: 
AC: 
2
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.490 
Heterozygous variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Conflicting classifications of pathogenicity 
Submissions summary: Uncertain:2Benign:1 
Revision: criteria provided, conflicting classifications
LINK: link 
Submissions by phenotype
not provided    Uncertain:2Benign:1 
Feb 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.